Literature DB >> 18438937

Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress.

Jingdong Qin1, Rajendra Goswami, Sylvia Dawson, Glyn Dawson.   

Abstract

Demyelination is a common result of oxidative stress in the nervous system, and we report here that the response of oligodendrocytes to oxidative stress involves the receptor for advanced glycation end products (RAGE). RAGE has not previously been reported in neonatal rat oligodendrocytes (NRO), but, by using primers specific for rat RAGE, we were able to show expression of messenger RNA (mRNA) for RAGE in NRO, and a 55-kDa protein was detected by Western blotting with antibodies to RAGE. Neonatal rat oligodendrocytes stained strongly for RAGE, suggesting membrane localization of RAGE. Addition of low concentrations of hydrogen peroxide (100 microM) initiated 55-kDa RAGE shedding from the cell membrane and the appearance of "soluble" 45-kDa RAGE in the culture medium, followed by restoration of RAGE expression to normal levels. Increasing hydrogen peroxide concentration (>200 microM) resulted in no restoration of RAGE, and the cells underwent apoptosis and necrosis. We further confirmed the observation in a human oligodendroglioma-derived (HOG) cell line. Both the antioxidant N-acetyl-L-cysteine and the broad-spectrum metalloproteases inhibitor TAPI0 were able partially to inhibit shedding of RAGE, suggesting involvement of metalloproteases in cleavage to produce soluble RAGE. The level of 55-kDa RAGE in autopsy brain of patients undergoing neurodegeneration with accompanying inflammation [multiple sclerosis and neuronal ceroid-lipofuscinosis (Batten's disease)] was much lower than that in age-matched controls, suggesting that shedding of RAGE might occur as reactive oxygen species accumulate in brain cells and be part of the process of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438937      PMCID: PMC2671024          DOI: 10.1002/jnr.21692

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  45 in total

1.  Characterization of a cell line derived from a human oligodendroglioma.

Authors:  G R Post; G Dawson
Journal:  Mol Chem Neuropathol       Date:  1992-06

2.  Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes.

Authors:  J E Bottenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  Hydrogen peroxide and endothelin-1 are novel activators of betacellulin ectodomain shedding.

Authors:  Michael P Sanderson; Catherine A Abbott; Hiroko Tada; Masaharu Seno; Peter J Dempsey; Andrew J Dunbar
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

Review 4.  RAGE (receptor for advanced glycation end products): a central player in the inflammatory response.

Authors:  Triantafyllos Chavakis; Angelika Bierhaus; Peter P Nawroth
Journal:  Microbes Infect       Date:  2004-11       Impact factor: 2.700

Review 5.  Protein glycation: a firm link to endothelial cell dysfunction.

Authors:  Jean-Luc Wautier; Ann Marie Schmidt
Journal:  Circ Res       Date:  2004-08-06       Impact factor: 17.367

6.  Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis.

Authors:  H Langemann; A Kabiersch; J Newcombe
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

7.  RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.

Authors:  Rashid Deane; Zhenhua Wu; Berislav V Zlokovic
Journal:  Stroke       Date:  2004-09-30       Impact factor: 7.914

8.  Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.

Authors:  Denise K H Chou; Jinghua Zhang; Frances I Smith; Peter McCaffery; Firoze B Jungalwala
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

9.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

10.  Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more
  20 in total

Review 1.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury.

Authors:  Rui Kang; Daolin Tang; Kristen M Livesey; Nicole E Schapiro; Michael T Lotze; Herbert J Zeh
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

Review 3.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

Review 4.  RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration.

Authors:  Kazimierz Gąsiorowski; Barbara Brokos; Valentina Echeverria; George E Barreto; Jerzy Leszek
Journal:  Mol Neurobiol       Date:  2017-02-06       Impact factor: 5.590

5.  Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.

Authors:  Michela Guglielmotto; Luca Giliberto; Elena Tamagno; Massimo Tabaton
Journal:  Front Aging Neurosci       Date:  2010-02-09       Impact factor: 5.750

6.  Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.

Authors:  Lih-Fen Lue; Douglas Gordon Walker; Sandra Jacobson; Marwan Sabbagh
Journal:  Future Neurol       Date:  2009

7.  RAGE gene polymorphisms in patients with multiple sclerosis.

Authors:  Zoltán Tiszlavicz; Zsofia Gyulai; Krisztina Bencsik; Zoltán Szolnoki; Agnes Katalin Kocsis; Ferenc Somogyvári; László Vécsei; Yvette Mándi
Journal:  J Mol Neurosci       Date:  2009-11       Impact factor: 3.444

8.  RAGE signaling contributes to neuroinflammation in infantile neuronal ceroid lipofuscinosis.

Authors:  Arjun Saha; Sung-Jo Kim; Zhongjian Zhang; Yi-Ching Lee; Chinmoy Sarkar; Pei-Chih Tsai; Anil B Mukherjee
Journal:  FEBS Lett       Date:  2008-10-21       Impact factor: 4.124

Review 9.  Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.

Authors:  Ling Zhang; Rolf Postina; Yingqun Wang
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

Review 10.  The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.

Authors:  Giovanna Vitaliti; Omidreza Tabatabaie; Nassim Matin; Caterina Ledda; Piero Pavone; Riccardo Lubrano; Agostino Serra; Paola Di Mauro; Salvatore Cocuzza; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.